Patents Assigned to DCV, Inc.
  • Publication number: 20030143190
    Abstract: Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.
    Type: Application
    Filed: May 14, 2002
    Publication date: July 31, 2003
    Applicant: DCV, Inc.
    Inventors: Subramanian Iyer, Tay N. Nguyen, Dauh-Rurng Wu, Ruye Xing
  • Publication number: 20030125573
    Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.
    Type: Application
    Filed: July 9, 2001
    Publication date: July 3, 2003
    Applicant: DCV, Inc., d/b/a Bio-Technical Resources
    Inventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin
  • Publication number: 20030092144
    Abstract: The invention provides a biological method of producing farnesol or geranylgeraniol.
    Type: Application
    Filed: July 20, 2001
    Publication date: May 15, 2003
    Applicant: DCV, Inc. d/b/a Bio-Technical Resources.
    Inventors: James R. Millis, Julie Maurina-Brunker, Thomas W. McMullin
  • Patent number: 6410755
    Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: June 25, 2002
    Assignee: DCV, Inc.
    Inventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin
  • Patent number: 6242227
    Abstract: The invention provides a method of producing &agr;-tocopherol and &agr;-tocopheryl esters. The method comprises using a biological system to produce farnesol or geranylgeraniol. Then, the farnesol or geranylgernaiol is chemically converted into &agr;-tocopherol or an &agr;-tocopheryl ester.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: June 5, 2001
    Assignees: DCV, Inc., Eastman Chemical Company
    Inventors: James R. Millis, Gabriel G. Saucy, Julie Maurina-Brunker, Thomas W. McMullin, John A. Hyatt
  • Patent number: 6225100
    Abstract: The present invention relates to novel arylsulfotransferases. In particular, the present invention relates to novel arylsulfotransferas from Clostridium and from Eubacterium innocuum.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: May 1, 2001
    Assignee: DCV, Inc.
    Inventors: Julie Maurina-Brunker, Alan D. Grund
  • Patent number: 6217865
    Abstract: The invention relates to blending eggs from all egg lots produced over a predetermined time period of the egg laying cycle of immunized avians, to form an antibody-containing substance. The administration of an effective amount of such a blended antibody-containing substance to a subject increases the efficacy of the antibody in the subject over that of administering a substance containing the same amount of antibody obtained from eggs collected over less than the predetermined period of time.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: April 17, 2001
    Assignee: DCV, Inc.
    Inventor: Jeffrey G. Hunchar
  • Patent number: 6167652
    Abstract: Application of a water-soluble salt of chitosan to the foliage of growing plants increases the yield of vegetables, tubers, cereal grains, fruits and blossoms. Plants so treated are healthier, sturdier, more resistant to drought and many varieties enjoy an extended period of production. The plants may be effectively and conveniently treated by spraying the foliage with a solution containing 0.01-1.5% wt. chitosan salt using conventional agricultural equipment and techniques.
    Type: Grant
    Filed: January 26, 1999
    Date of Patent: January 2, 2001
    Assignee: DCV, Inc.
    Inventors: George E. Heinsohn, August S. Bjornson
  • Patent number: 6136985
    Abstract: The present invention provides CLA esters and uses thereof. More particularly, the present invention provides a composition for topical use comprising CLA esters and a topical carrier. In addition, the present invention specifically provides tocopheryl CLA esters, ascorbyl CLA esters and retinyl CLA esters.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: October 24, 2000
    Assignee: DCV, Inc.
    Inventor: James R. Millis
  • Patent number: 6086878
    Abstract: The invention is directed to a method and food product for achieving at least one of the following: increasing muscle protein or reducing fat in an animal. The method comprises administering to the animal an effective amount of a composition comprising a gastrointestinal neuro-modulator antibody in order to neutralize the gastrointestinal neuro-modulator.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: July 11, 2000
    Assignee: DCV, Inc.
    Inventors: Orn Adalsteinsson, Sandra G. Fitzpatrick-McElligott, Jeffrey G. Hunchar
  • Patent number: 5945159
    Abstract: The invention is directed to a method for the encapsulation of very finely divided solids within a continuous impervious coating of thermoplastic material. The method is carried out with continuous agitation during which the particles are coated with a plurality of sprayed layers of thermoplastic coating material while maintaining the particles in free-flowing powder consistency during the coating steps.
    Type: Grant
    Filed: December 12, 1996
    Date of Patent: August 31, 1999
    Assignee: DCV, Inc.
    Inventor: Joseph L. Sell
  • Patent number: 5932250
    Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 3, 1999
    Assignee: DCV, Inc.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5922774
    Abstract: Method for repelling insect herbivores from plant surfaces and deterring them from feeding on plant surfaces by applying an aqueous dispersion of polycyclic quinone or precursor thereof to the foliage of the plant and/or to the surrounding soil in which the plant is rooted.
    Type: Grant
    Filed: October 22, 1996
    Date of Patent: July 13, 1999
    Assignee: DCV, Inc.
    Inventor: Anna Louise Winslow
  • Patent number: 5922110
    Abstract: A water-soluble, biodegradable filter medium for removing entrained solid and/or liquid particles from an air stream, and a method of use thereof are disclosed. The filter medium is a solid solution of starch and a biodegradable, water-soluble synthetic polymer. After use, the filter medium is disposed of in an environmentally sound fashion. In particular, the filter medium is dissolved in water and the solid and/or liquid particles collected thereon are removed from the resulting aqueous solution of starch and polymer by decantation and the polymer and starch biodegraded using a conventional biological water treatment process.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: July 13, 1999
    Assignee: DCV, Inc.
    Inventors: Harvey L. Weaver, Donald Mark Cyron
  • Patent number: 5910622
    Abstract: Method for treating fibrous cellulosic materials using an aqueous cationic treating solution containing a cyclic polyhydroxy compound and choline chloride, by which dye uptake of the material, and the environmental effects of the subsequent dyeing process are improved.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: June 8, 1999
    Assignee: DCV, Inc.
    Inventor: George L. Brodmann
  • Patent number: 5853765
    Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 29, 1998
    Assignee: DCV, Inc.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5849349
    Abstract: Eggs that affect lipid and cholesterol levels obtained from avian species that are hyperimmunized against a variety of bacterial antigens are disclosed. These eggs are useful as a dietary supplement for humans and other animals.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 15, 1998
    Assignee: DCV, Inc.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5792631
    Abstract: The present invention is directed to methods for the production of ascorbic acid by culturing organisms of the species C. protothecoides and recovering ascorbic acid from the fermentation medium.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 11, 1998
    Assignee: DCV, Inc.
    Inventor: Jeffrey Running